Novo Nordisk stock is sliding again — and the Wegovy pill’s surprise miss is partly to blame
The Danish drugmaker also revealed an improved outlook for the year.
This is a summary aggregated from MarketWatch. Read the complete article on the original site:
Read full article at MarketWatch
